Global Gene Therapy Market Analysis

NEW YORK, July 22, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Global Gene Therapy Market Analysis

http://www.reportlinker.com/p0324817/Global-Gene-Therapy-Market-Analysis.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Biological_Therapy

Gene therapy is the treatment of a disease by replacing, altering, or supplementing a gene that is absent or abnormal and whose absence or abnormality is causing the disease. It has evolved as one of the most sought after research objectives for 'difficult to cure' diseases. The gene therapy market in spite of presenting few marketable products and being nascent in terms of revenue generation holds tremendous growth potential. As per a new estimation carried out in our latest study, the global gene therapy industry has the potential to become a multi-million dollar industry by the end of 2017 as new products, especially those in the advanced stage of clinical studies or with pending approvals, may enter the market to boost the growth.

According to RNCOS' new research report, "Global Gene Therapy Market Analysis", major focus has been made on the ongoing clinical trials for the development of innovative products. Majority trials are focused on oncology and they prove promising on global scale for US. In this context, the study provides a comprehensive overview of the various aspects of clinical trials in the gene therapy market such as phases, geographies, vector types etc.

The report provides an in-depth and prudent analysis of the industry and research developments taking place at the global level. Primarily the market is presently dominated by oncology applications with several companies and academic institutions focusing on novel and 'difficult to treat' cancers. Other therapeutic areas seeing developments on gene therapy include cardiac conditions, genetic disorders and neurological diseases. An effective analysis of the key therapeutic areas has been included in the report.

Brief overview of the key geographies in the gene therapy market and the regulatory scenario governing the industry has also been included in the study to present a balanced outlook. The report covers how major trends and drivers, including gene silencing, advanced therapies etc will propel the industry's growth. With a view to understanding the competitive landscape, the profiles of key market players are included in the report to present a complete picture of the global gene therapy market.1. Analyst View2. Research Methodology3. Gene Therapy - An Introduction3.1 Classification of Gene Therapy Techniques3.2 Physical Methods of Gene Transfer3.2.1 Electroporation3.2.2 Hydrodynamic3.2.3 Microinjection3.2.4 Particle Bombardment3.2.5 Ultrasound-mediated Transfection3.3 Vectors for Gene Therapy3.3.1 Adenoviral Vectors3.3.2 Adeno-associated Virus Vectors3.3.3 Retroviral Vectors3.3.4 Lentiviral Vectors3.3.5 Plasmid DNA4. Industry Trends and Drivers4.1 Gene Silencing: Gaining Momentum4.2 Advanced Therapies: Combining Gene Therapy and Stem Cell Technology4.3 Immunodeficiency Syndromes: The Focus of Gene Therapy4.4 Nanotechnology: Empowering Gene Therapy4.5 Gene Therapy: A New Hope to Treat Blindness5. Gene Therapy Clinical Trial Assessment5.1 By Geography5.2 By Indication5.3 By Gene Type5.4 By Vector5.5 By Clinical Trial Phase6. Industry Overview6.1 Market Size and Growth6.2 By Application6.2.1 Oncology6.2.1.1 Key Approaches6.2.1.2 Recent Advancements6.2.2 Infectious Diseases6.2.2.1 Key Approaches6.2.2.2 Recent Advancements6.2.3 Genetic Disorders6.2.3.1 Key Approaches6.2.3.2 Recent Advancements6.2.4 Cardiovascular Disorders6.2.4.1 Key Approaches6.2.4.2 Recent Advancements6.2.5 Diabetes Mellitus6.2.5.1 Key Approaches6.2.5.2 Recent Advancements6.2.6 Neurological Disorders6.2.6.1 Key Approaches6.2.6.2 Recent Advancements6.3 Key Geographical Markets6.3.1 US6.3.1.1 Regulatory Landscape6.3.1.2 Recent Advancements6.3.2 Europe6.3.2.1 Regulatory Landscape6.3.2.2 Recent Advancements6.3.3 Australia6.3.3.1 Regulatory Landscape6.3.3.2 Recent Advancements6.3.4 Canada6.3.4.1 Regulatory Landscape6.3.4.2 Recent Advancements6.3.5 Japan6.3.5.1 Regulatory Landscape6.3.5.2 Recent Advancements6.3.6 China6.3.6.1 Regulatory Landscape6.3.7 India6.3.7.1 Regulatory Landscape6.3.7.2 Recent Advancements6.4 Advanced Gene Therapy Drugs6.4.1 Collategene6.4.2 Allovectin-76.4.3 Generx7. Key Players Analysis7.1 AnGes MG, Inc7.2 Ark Therapeutics7.3 Ceregene, Inc7.4 Cobra Biologics7.5 GenVec, Inc7.6 Genzyme Corporation7.7 Vical, Inc7.8 Oxford BioMedica

List of Figures:

Figure 5-2: Percentage of Gene Types Transferred in Gene Therapy Trials till 2012

Figure 5-3: Percentage of Vectors Used in Gene Therapy Trials till 2012

See the original post here:
Global Gene Therapy Market Analysis